Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study

The aim of this EMINENTS prospective, single-center, open-label, single-arm study was to evaluate the cumulative efficacy and safety of reduced doses of everolimus (maintenance therapy) in patients with tuberous sclerosis and subependymal giant cell astrocytoma (SEGA). Methods: The trial included 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobeff, Katarzyna, Krajewska, Karolina, Baranska, Dobromila, Kotulska, Katarzyna, Jozwiak, Sergiusz, Mlynarski, Wojciech, Trelinska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062974/
https://www.ncbi.nlm.nih.gov/pubmed/33897576
http://dx.doi.org/10.3389/fneur.2021.581102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062974/
https://www.ncbi.nlm.nih.gov/pubmed/33897576
http://dx.doi.org/10.3389/fneur.2021.581102

Ejemplares similares